SEC
Filings

Menu

Tabs Financials

SEC Filings

Filing date Form Description Filing Group View
4

Statement of changes in beneficial ownership of securities

3,4,5
View HTML
4

Statement of changes in beneficial ownership of securities

3,4,5
View HTML
4

Statement of changes in beneficial ownership of securities

3,4,5
View HTML
4

Statement of changes in beneficial ownership of securities

3,4,5
View HTML
4

Statement of changes in beneficial ownership of securities

3,4,5
View HTML
SC 13G

A statement of beneficial ownership of common stock by certain persons

Other
View HTML
424B3

Form of prospectus reflecting facts events constituting substantive change from last form

Registration Statements
View HTML
424B3

Form of prospectus reflecting facts events constituting substantive change from last form

Registration Statements
View HTML
424B3

Form of prospectus reflecting facts events constituting substantive change from last form

Registration Statements
View HTML
EFFECT

EFFECT

Other
View HTML

Data provided by Kaleidoscope.

 

Investor Contact

Richard Eisenstadt
Chief Financial Officer

Email: reisenstadt@altimmune.com

 

Email Alerts

Automatically receive Altimmune, Inc. financial information by e-mail

Subscribe